Filtros de búsqueda

Lista de obras de

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.

artículo científico publicado en 2018

A Feasibility Study Evaluating Extraoral Photobiomodulation Therapy for Prevention of Mucositis in Pediatric Hematopoietic Cell Transplantation

artículo científico publicado en 2016

A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.

artículo científico publicado en 2016

A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma

artículo científico publicado en 2020

A Retrospective Multicenter Study of Fatal Pediatric Melanoma

artículo científico publicado en 2020

A finite mixture survival model to characterize risk groups of neuroblastoma

artículo científico publicado en 2009

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency

artículo científico publicado en 2014

A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project

artículo científico publicado en 2020

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1

artículo científico publicado en 2013

A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study

artículo científico publicado en 2012

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

artículo científico publicado en 2009

ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.

artículo científico publicado en 2011

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma

artículo científico publicado en 2014

APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial

artículo científico publicado en 2006

Activating mutations in ALK provide a therapeutic target in neuroblastoma

artículo científico publicado en 2008

Advances in Risk Classification and Treatment Strategies for Neuroblastoma

artículo científico publicado en 2015

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project

artículo científico publicado en 2020

Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group

artículo científico publicado en 2014

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group

artículo científico publicado en 2009

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study

artículo científico publicado en 2005

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

artículo científico publicado en 2010

Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study

artículo científico publicado en 2019

Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study

artículo científico publicado en 2010

Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group

artículo científico publicado en 2008

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

artículo científico

Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma

artículo científico publicado en 2006

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.

artículo científico publicado en 2015

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study

artículo científico publicado en 2015

Balancing education and service in graduate medical education: data from pediatric trainees and program directors

artículo científico publicado en 2014

CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression

artículo científico publicado en 2011

CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas

artículo científico publicado en 2008

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project

artículo científico publicado en 2010

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG project

artículo científico publicado en 2011

Characteristics of non-melanoma skin cancer in children without identifiable risk factors

artículo científico publicado en 2020

Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency

artículo científico publicado en 2020

Children's Oncology Group's 2013 blueprint for research: neuroblastoma

artículo científico

Chromosome 1p and 11q deletions and outcome in neuroblastoma

artículo científico publicado en 2005

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

artículo científico publicado en 2008

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project

artículo científico publicado en 2011

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group

artículo científico publicado en 2008

Clinical significance of NTRK family gene expression in neuroblastomas ⬇️

artículo científico publicado el 11 de octubre de 2011

Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma

artículo científico publicado en 2012

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project

artículo científico publicado en 2014

Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma ⬇️

artículo científico publicado el 15 de agosto de 2012

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

artículo científico publicado en 2009

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

artículo científico publicado en 2009

Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations

artículo científico publicado en 2020

Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group

artículo científico publicado en 2011

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

artículo científico publicado en 2019

Copy number variation at 1q21.1 associated with neuroblastoma

artículo científico publicado en 2009

Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group

artículo científico publicado en 2019

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931

scientific article published on 16 July 2018

Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group

artículo científico publicado en 2007

Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center

artículo científico publicado en 2016

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531

artículo científico publicado en 2018

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group

scientific article published on 21 August 2018

Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaboration

artículo científico publicado en 2013

Development of an open-source, flexible framework for interinstitutional data sharing and collaboration.

artículo científico publicado en 2012

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease

scientific article published on 01 February 2007

Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study

artículo científico publicado en 2006

EPN-14PEDIATRIC EPENDYMOMA: MULTI-INSTITUTIONAL EXPERIENCE REVEALS POOR LONG-TERM OVERALL SURVIVAL DESPITE FAVORABLE FIVE-YEAR OUTCOMES.

artículo científico publicado en 2016

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial

artículo científico publicado en 2019

Effect of Weight on Outcomes of Children Undergoing Hematopoietic Cell Transplantation ⬇️

artículo científico publicado el 28 de noviembre de 2012

Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study

artículo científico publicado en 2004

End-of-Life Care Patterns Associated with Pediatric Palliative Care among Children Who Underwent Hematopoietic Stem Cell Transplant

artículo científico publicado en 2016

Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects

artículo científico publicado en 2005

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group ⬇️

artículo científico publicado el 25 de septiembre de 2012

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

article

Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group/Pediatric Oncology Group

artículo científico publicado en 2003

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

artículo científico publicado en 2005

Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: A Pediatric Oncology Group study: A Report from the Children's Oncology Group ⬇️

artículo científico publicado el 28 de junio de 2012

Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses

artículo científico publicado en 2008

Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors

artículo científico publicado en 2020

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

artículo científico publicado en 2018

Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency

artículo científico publicado en 2020

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

artículo científico publicado en 2010

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project

artículo científico publicado en 2011

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

artículo científico publicado en 2017

Health Literacy and Clinical Outcomes Following Hematopoietic Stem-Cell Transplantation

artículo científico publicado en 2022

Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1

artículo científico publicado en 2014

Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.

artículo científico publicado en 2017

Hyperdiploidy Plus NonamplifiedMYCNConfers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study

article

Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project

artículo científico publicado en 2015

Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report

artículo científico publicado en 2014

Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma

artículo científico publicado en 2016

Incidence and causes of hospital readmission in pediatric patients after hematopoietic cell transplantation

artículo científico publicado en 2015

Influence of neuroblastoma stage on serum-based detection of MYCN amplification

artículo científico publicado en 2009

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma

artículo científico publicado en 2019

Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients

artículo científico publicado en 2014

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

artículo científico publicado en 2010

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number

artículo científico publicado en 2006

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma

artículo científico publicado en 2006

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

artículo científico publicado en 2009

International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.

artículo científico publicado en 2006

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial

Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group

scientific article published on 28 April 2020

Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial

artículo científico publicado en 2017

Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database

artículo científico publicado en 2014

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

artículo científico publicado en 2009

Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project

artículo científico publicado en 2008

MB-66PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHLDREN WITH Wnt POSITIVE STANDARD RISK MEDULLOBLASTOMA.

artículo científico publicado en 2016

MEDU-34. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA

artículo científico publicado en 2019

MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin.

artículo científico publicado en 2016

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group

artículo científico publicado en 2017

MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN

scientific article published on 01 November 2000

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.

artículo científico publicado en 2016

Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

artículo científico publicado en 2019

Malignant mediastinal germ cell tumors: an intergroup study.

artículo científico publicado en 2001

Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study.

artículo científico publicado en 2003

Mechanisms of CHD5 Inactivation in Neuroblastomas ⬇️

artículo científico publicado el 31 de enero de 2012

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database

artículo científico publicado en 2014

Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome

artículo científico publicado en 2007

Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation

artículo científico publicado en 2022

Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study.

artículo científico

N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma.

artículo científico publicado en 2011

Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study

artículo científico publicado en 2000

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

artículo científico publicado en 2017

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project

artículo científico publicado en 2013

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group

artículo científico publicado en 2013

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

artículo científico publicado en 2016

Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study

artículo científico publicado en 2016

Non-malignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children

artículo científico publicado en 2018

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency

scientific article published on 12 June 2018

ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma

artículo científico publicado en 2008

One- and two-stage designs for stratified phase II clinical trials

artículo científico publicado en 2005

Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group

artículo científico publicado en 2014

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

artículo científico publicado en 2010

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.

artículo científico publicado en 2012

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group

artículo científico publicado en 2009

Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy

artículo científico publicado en 2005

Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group

artículo científico publicado en 2008

Overcoming reprogramming resistance of Fanconi anemia cells ⬇️

artículo científico publicado el 27 de febrero de 2012

POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group

artículo científico publicado en 2006

Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation

artículo científico publicado en 2016

Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors.

artículo científico publicado en 2015

Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.

artículo científico publicado en 2012

Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group

artículo científico publicado en 2010

Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee

artículo científico publicado en 2012

Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study

artículo científico publicado en 2010

Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study

artículo científico publicado en 2010

Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group

artículo científico publicado en 2011

Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study

artículo científico publicado en 2011

Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease

artículo científico publicado en 2020

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

artículo científico publicado en 2009

Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)

artículo científico publicado en 2019

Predictors of neoplastic disease in children with isolated pituitary stalk thickening.

artículo científico publicado en 2013

Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.

artículo científico publicado en 2005

Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families

artículo científico publicado en 2014

Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study

artículo científico publicado en 2018

Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study

artículo científico publicado en 2006

Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor).

artículo científico publicado en 2009

Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database

artículo científico publicado en 2016

Prognostic significance ofEPHB6, EFNB2, andEFNB3 expressions in neuroblastoma

artículo científico publicado en 2000

Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.

artículo científico publicado en 2011

Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study

artículo científico publicado en 2020

Provider Perspectives on Use of Medical Marijuana in Children With Cancer

artículo científico publicado en 2017

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

artículo científico publicado en 2013

Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials

artículo científico publicado en 2020

Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study

artículo científico publicado en 2010

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Grou

artículo científico publicado en 2004

Reply to J. Stenman et al.

artículo científico publicado en 2017

Reply to K. Beiske et al

scientific article published on 15 September 2020

Reply to N.-K.V. Cheung et al

artículo científico publicado en 2014

Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma

artículo científico publicado en 2017

Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study

artículo científico publicado en 2004

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group

artículo científico publicado en 2012

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.

artículo científico publicado en 2017

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

artículo científico publicado en 2017

Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults

artículo científico publicado en 2019

Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2017

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study

scientific article published on 09 April 2019

SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings

artículo científico publicado en 2015

Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study

artículo científico publicado en 2017

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project ⬇️

artículo científico publicado el 13 de septiembre de 2012

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group

artículo científico publicado en 2013

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma

artículo científico publicado en 2016

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database

artículo científico publicado en 2008

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project

artículo científico publicado en 2014

Sleep dysfunction in long term survivors of craniopharyngioma

artículo científico

Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System

scientific article published on 01 December 2018

Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients

scientific article published on 01 October 2018

Sun exposure and protection practices in children after allogeneic hematopoietic stem cell transplantation: A Survey-Based Cross-Sectional Cohort Study

scientific article published on 13 August 2019

Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group

artículo científico publicado en 2006

Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future

artículo científico publicado en 2020

The Effectiveness of a Hospital-Based School Liaison Program: A Comparative Study of Parental Perception of School Supports for Children With Pediatric Cancer and Neurofibromatosis Type 1

artículo científico publicado en 2018

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

artículo científico publicado en 2008

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

artículo científico publicado en 2008

The challenge of defining "ultra-high-risk" neuroblastoma

scientific article published on 26 November 2018

The clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study

artículo científico publicado en 2018

The effect of neoadjuvant chemotherapy and surgery in children with malignant germ cell tumors of the genital region: a pediatric intergroup trial.

artículo científico publicado en 2003

The genetic landscape of high-risk neuroblastoma

artículo científico publicado en 2013

The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

artículo científico publicado en 2020

The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency

artículo científico publicado en 2020

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives

artículo científico publicado en 2005

The use of central laboratories and remote electronic data capture to risk-adjust therapy for pediatric acute lymphoblastic leukemia and neuroblastoma

artículo científico publicado en 2010

Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).

artículo científico publicado en 2013

Trajectory of Material Hardship and Income Poverty in Families of Children Undergoing Chemotherapy: A Prospective Cohort Study

artículo científico publicado en 2015

Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival

artículo científico publicado en 2012

Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience

artículo científico publicado en 2001

Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.

artículo científico publicado en 2004

Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study

artículo científico publicado en 2006

Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study

artículo científico publicado en 2002

Tumor histology during induction therapy in patients with high‐risk neuroblastoma ⬇️

artículo científico publicado el 11 de diciembre de 2011

Use and Effectiveness of Gonadotropin-Releasing Hormone Agonists for Prophylactic Menstrual Suppression in Postmenarchal Women Who Undergo Hematopoietic Cell Transplantation

artículo científico publicado en 2015

Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system

artículo científico publicado en 2014

Voriconazole phototoxicity in children: a retrospective review

artículo científico publicado en 2014

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival

artículo científico publicado en 2009

miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

artículo científico publicado en 2011

microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma

artículo científico publicado en 2010

p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.

artículo científico publicado en 2001

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda